Ligand validation:2GO3

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GO3_IMD_B_802	63%	73%	0.165	0.96	0.61	0.44	-	-	0	0	100%	1
2GO3_IMD_A_801	40%	73%	0.219	0.932	0.58	0.47	-	-	0	0	100%	1
2GO3_IMD_A_803	18%	73%	0.368	0.962	0.58	0.46	-	-	0	0	100%	0.5
2GO3_IMD_B_804	5%	72%	0.507	0.926	0.59	0.48	-	-	0	0	100%	0.5
4U3B_IMD_A_301	69%	72%	0.109	0.922	0.39	0.7	-	-	0	0	100%	1
4U3D_IMD_A_301	57%	72%	0.115	0.889	0.36	0.7	-	-	0	0	100%	1
3P76_IMD_A_272	34%	18%	0.167	0.85	1.32	2.19	-	1	1	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
1W8K_IMD_A_1476	99%	44%	0.042	0.978	0.79	1.36	-	1	0	0	100%	1
2ASN_IMD_X_202	99%	67%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.